Corelogix Asclepius JV, LLC

Corelogix Asclepius JV, LLC is an SBA-certified 8(a) small disadvantaged business joint venture headquartered in Sterling, Virginia, that specializes in providing information technology services to federal agencies. The company is registered in SAM.gov and holds a current certification as a small disadvantaged business. Through its federal contracting activities, Corelogix Asclepius JV has demonstrated expertise in delivering customized IT solutions and support services to support critical federal operations.

The company has established a sustained track record of providing IT support services to the National Cancer Institute's Center for Cancer Research Office of Information Technology through multiple delivery orders issued under the 8(a) STARS III Government Wide Acquisition Contract. These delivery orders, totaling approximately $5.2 million, demonstrate the breadth of services the company provides. Specifically, the company has delivered IT support services valued at $3.71 million with performance executed in Potomac, Maryland, and a labor-hour contract extending through September 3, 2027. Additionally, Corelogix Asclepius JV provided compliance validation services valued at $259,914.21 on a firm fixed-price basis, completed in September 2023, and project management and application support services valued at $1.26 million on a labor-hour basis, also completed in September 2023. All delivery orders were awarded on an 8(a) sole-source basis, reflecting the contractor's specialized capabilities and the National Cancer Institute's confidence in the company's ability to deliver mission-critical services without competitive procurement. The services performed support the Institute's IT infrastructure operations, systems support, compliance validation, and project management requirements essential to the Institute's cancer research mission.

Corelogix Asclepius JV, LLC holds a prime contract position under the 8(a) STARS III Government Wide Acquisition Contract, a $50 billion multiple-award indefinite delivery/indefinite quantity vehicle established by the General Services Administration's Federal Acquisition Service on July 2, 2021. The 8(a) STARS III GWAC was competitively awarded to 8(a) certified small disadvantaged businesses and is designed to streamline federal procurement of customized information technology services across civilian federal agencies while advancing small business contracting objectives. Under this vehicle, the contract supports performance-based, fixed-price, time-and-materials, and labor-hour task orders spanning data management, IT operations, security, systems design, and related IT service categories. The National Cancer Institute has been the primary agency awarding delivery orders to Corelogix Asclepius JV under the 8(a) STARS III GWAC, with all issued orders representing specialized IT service requirements supporting the Center for Cancer Research's operational and infrastructure needs. The 8(a) STARS III GWAC vehicle remains active with an ultimate completion date of July 1, 2026, providing Corelogix Asclepius JV continued opportunity to compete for and deliver IT services to federal agencies under this established framework.